Overview Financials News + Filings
|
|
QLY Biotech Group Corp.
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Aug-31-22 | Aug-31-21 | Aug-31-20 |
| | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.2 | |
| |
| Returns on Capital |
| ROIC (including intangibles) | | 245.6% | 489.0% |
| ROE | | 447.8% | -56.3% |
| ROA | | -373.0% | -42.3% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | | 0.0 | 0.0 |
| Days payables outstanding | | 397.6 | |
| Cash conversion cycle | | -397.6 | 0.0 |
|